COCRYSTAL PHARMA, INC. Finance Lease, Right-of-Use Asset, Amortization
COCRYSTAL PHARMA, INC. (COCP) reported Finance Lease, Right-of-Use Asset, Amortization of $47.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2021-05-17
- COCRYSTAL PHARMA, INC. finance lease, right-of-use asset, amortization for the quarter ending 2021-03-31 was $47.00K, a 6.82% increase year-over-year.
- COCRYSTAL PHARMA, INC. finance lease, right-of-use asset, amortization for the quarter ending 2020-12-31 was $46.00K, a 9.52% increase year-over-year.
- COCRYSTAL PHARMA, INC. finance lease, right-of-use asset, amortization for the quarter ending 2020-03-31 was $44.00K, a 2.33% increase year-over-year.
- COCRYSTAL PHARMA, INC. finance lease, right-of-use asset, amortization for the quarter ending 2019-12-31 was $42.00K.
- COCRYSTAL PHARMA, INC. finance lease, right-of-use asset, amortization for fiscal 2020 was $179.00K, a 14.74% increase from fiscal 2019.
- COCRYSTAL PHARMA, INC. finance lease, right-of-use asset, amortization for fiscal 2019 was $156.00K.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2021-03-31 | $47.00K 10-Q · filed 2021-05-17 | $93.00K derived: sum of 2 quarters · filed 2021-05-17 | ||
| 2020-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $179.00K 10-K · filed 2021-03-17 | ||
| 2020-09-30 | $133.00K 10-Q · filed 2020-11-13 | |||
| 2020-03-31 | $44.00K 10-Q · filed 2021-05-17 | $86.00K derived: sum of 2 quarters · filed 2021-05-17 | ||
| 2019-12-31 | $42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $156.00K 10-K · filed 2021-03-17 | ||
| 2019-09-30 | $114.00K 10-Q · filed 2020-11-13 | |||
| 2019-03-31 | $43.00K 10-Q · filed 2020-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |